Talphera (TLPH) EBITDA Margin Growth (5y) (2016 - 2025)
Talphera (TLPH) EBITDA Margin Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Talphera | 47.31 Mn | 9.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -34.15 Mn |
| Mar 31, 2025 | -669,430.00 |
| Dec 31, 2023 | 26,650.00 |
| Sep 30, 2023 | -35,393.00 |
| Jun 30, 2023 | -69,432.00 |
| Mar 31, 2023 | 236,887.00 |
| Mar 31, 2022 | -164,674.00 |
| Dec 31, 2021 | -40.86 Mn |
| Sep 30, 2021 | -27,090.00 |
| Jun 30, 2021 | -207,705.00 |
| Mar 31, 2021 | -150,732.00 |
| Dec 31, 2020 | -81,697.00 |
| Sep 30, 2020 | -70,665.00 |
| Jun 30, 2020 | 18,847.00 |
| Mar 31, 2020 | 219,264.00 |
| Dec 31, 2019 | 205,574.00 |
| Sep 30, 2019 | -212,093.00 |
| Jun 30, 2019 | 1.51 Mn |
| Mar 31, 2019 | 384,538.00 |
| Dec 31, 2018 | -180,508.00 |